Combination of aspirin and clopidogrel for the prevention of thrombosis: Implications for the dental practitioner

Paulomi R. Shah, Juan F. Yepes, John A. Valenza

Research output: Contribution to journalArticle

2 Scopus citations


The use of aspirin and Clopidogrel as effective antiplatelet therapy in preventing secondary thromboembolic events is well-established. However, there is controversy among dentists and physicians regarding the appropriate dental management of patients receiving dual antiplatelet therapy due to the lack of clinical studies about hemorrhagic risk in these patients. Indications for modifying dual antiplatelet therapy-whether it is done by altering doses, switching to monotherapy, or discontinuing It completely-occur infrequently, as most patients can be treated in a dental office setting. In all cases, patients must be managed jointly by the dentist and physician, taking into account the patient's medical and dental history. This article reviews the current use of aspirin and clopidogrel as combination therapy, examining their effect on platelet function, the associated hemorrhagic risk during dental procedures for patients using this therapy, and how oral health care providers can manage these patients safely and effectively.

Original languageEnglish (US)
Pages (from-to)517-522
Number of pages6
JournalGeneral dentistry
Issue number6
StatePublished - Nov 1 2007


ASJC Scopus subject areas

  • Dentistry(all)

Cite this